Aurinia Pharmaceuticals (AUPH) Profit After Tax Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | 49.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.05% |
| Dec 31, 2025 | 116.11% |
| Sep 30, 2025 | 76.62% |
| Jun 30, 2025 | 37.61% |
| Mar 31, 2025 | 37.86% |
| Dec 31, 2024 | 26.89% |
| Sep 30, 2024 | 31.72% |
| Jun 30, 2024 | 26.31% |
| Mar 31, 2024 | 40.25% |
| Dec 31, 2023 | -49.31% |
| Sep 30, 2023 | 31.66% |
| Jun 30, 2023 | 24.35% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | 8.91% |
| Sep 30, 2022 | 27.36% |
| Jun 30, 2022 | -35.64% |
| Mar 31, 2022 | -38.72% |
| Dec 31, 2021 | -31.68% |
| Sep 30, 2021 | -39.93% |
| Jun 30, 2021 | -44.11% |
| Mar 31, 2021 | -48.20% |
| Dec 31, 2020 | -34.32% |
| Sep 30, 2020 | -47.53% |
| Sep 30, 2019 | -52.80% |
| Jun 30, 2019 | -23.57% |
| Sep 30, 2018 | -48.29% |
| Jun 30, 2018 | -18.94% |